Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EML4 | Q9HC35 | 7/20 | 0.46 |
| ▸ | ALK | Q9UM73 | 7/20 | 0.46 |
| ▸ | RET | P07949 | 8/20 | 0.46 |
| ▸ | ROS1 | P08922 | 8/20 | 0.46 |
| ▸ | FLT3 | P36888 | 8/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 8/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | CDK4 | P11802 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CCND3 | P30281 | 1/20 | 0.39 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24943806 | 1.00 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944743 | 1.00 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL29173297 | 0.93 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL30205539 | 0.93 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944366 | 0.93 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944749 | 0.93 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944365 | 0.93 | EML4 (0.46) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944163 | 0.91 | EML4 (0.51) | EML4ALKRETROS1FLT3 | |
| SCHEMBL30205743 | 0.91 | EML4 (0.51) | EML4ALKRETROS1FLT3 | |
| SCHEMBL24944963 | 0.90 | EML4 (0.48) | EML4ALKRETROS1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023001794-A1 | SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2023-01-26 | — | — | WO | disclosed |